Morgan Stanley Maintains Overweight on Johnson & Johnson, Lowers Price Target to $292
Benzinga Newsdesk 2 weeks ago
Analyst RatingsNewsPrice TargetHot
Morgan Stanley analyst Terence Flynn maintains Johnson & Johnson (NYSE:JNJ) with a Overweight and lowers the price target from $294 to $292.
Morgan Stanley analyst Terence Flynn maintains Johnson & Johnson (NYSE:JNJ) with a Overweight and lowers the price target from $294 to $292.